CDMO Activity Tracker: CDMOs expand operations in cell and gene therapies, biologics, HPAPIs
The Covid-19 pandemic expedited the
growth of contract development and manufacturing organizations
DMF submissions rise 12.1% in 2022; India sees 10.6% drop in Type II filings
In 2022, the world finally began to emerge out of Covid-related
restrictions. Though 2020 and 2021
Cannabinoids in pharmaceutical development
The development of
cannabinoids in the pharmaceutical industry has exploded over the past few
year
Sales Forecast of FDA’s Novel Drugs Approvals in 2018
The year 2018 was a landmark year for the US Food and Drug Administration (FDA) as the agency approv